Ledger.Open graph →
SEC Form D · Amendment · filed March 31, 2016

Semma Therapeutics, Inc

Offering
$25.0M
Sold
$15.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Michael Episcope · chicago, ILExec · DirectorGarrett Finney · Houston, TXExecJ. A. Gonzalez · Houston, TXExec · DirectorJim Scopa · Cambridge, MADirectorShaun J. Mcnulty · Babraham, Cambridge, United KingdomDirectorRobert Millman · Cambridge, MAExec · DirectorStephen Knight · Cambridge, MADirectorDavid M. Talla · Los Angeles, CADirectorDavid Scherer · Chicago, ILDirectorRussell A. Radoff · Houston, TXDirectorMichael Bland · Houston, TXDirectorTodd Foley · Cambridge, MAExec · DirectorMitch Finer · Cambridge, MADirectorKingsley Taft · Boston, MAExecMark Galvin · Portsmouth, NHExec · DirectorWilliam Moon · Ruston, LAExec · DirectorDominick J. D'Eramo · WILMINGTON, DEDirectorRichard L. Latto · Stamford, CTExec · DirectorWilliam Sahlman · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗